Content about Pfizer

January 8, 2014

Generic drug maker Mylan has hired a former Pfizer executive to its executive leadership team.

PITTSBURGH — Generic drug maker Mylan has hired a former Pfizer executive to its executive leadership team.

The company announced Wednesday the appointment of Adele Gulf as EVP global collaboration and strategic operations. Before working for Mylan, Gulfo served as regional president of Latin America for Pfizer's Emerging Markets Business Unit, overseeing more than 4,000 employees in 23 countries and achieving more than $3 billion in sales in Latin America in 2012.

January 7, 2014

Mylan has launched a generic version of a drug made by Pfizer for treating bladder problems, the company said Tuesday.

PITTSBURGH — Mylan has launched a generic version of a drug made by Pfizer for treating bladder problems, the company said Tuesday.

Mylan announced the launch of tolterodine tartrate extended-release capsules in the 2-mg and 4-mg strengths. The drug is used to treat overactive bladder with symptoms of urinary incontinence, urgency and frequency.

The drug is a generic version of Pfizer's Detrol LA. Tolterodine tartrate extended-release capsules had sales of about $571.5 million during the 12-month period that ended in September, according to IMS Health.

January 3, 2014

Teva Pharmaceutical Industries has launched an authorized generic version of a drug used to treat overactive bladder, the company said Friday.

JERUSALEM — Teva Pharmaceutical Industries has launched an authorized generic version of a drug used to treat overactive bladder, the company said Friday.

December 26, 2013

Earlier this year, the IMS Institute for Healthcare Informatics, the research wing of the healthcare industry analysis firm IMS Health, dropped a bombshell when it showed that U.S. spending on drugs fell in 2012, the first time that had happened in 55 years.

Earlier this year, the IMS Institute for Healthcare Informatics, the research wing of the healthcare industry analysis firm IMS Health, dropped a bombshell when it showed that U.S. spending on drugs fell in 2012, the first time that had happened in 55 years. But according to IMS’ latest figures, it was not the start of a trend.

December 18, 2013

Mylan has acquired rights to an experimental respiratory drug made by Pfizer, Mylan said.

PITTSBURGH — Mylan has acquired rights to an experimental respiratory drug made by Pfizer, Mylan said Wednesday.

The drug maker said it had bought exclusive worldwide development, manufacturing and commercialization rights to the drug, which was not named, but was described as a long-acting muscarinic antagonist about to enter phase-2b, or mid-stage, clinical trials. Mylan said it would develop the drug into combination therapies and that they would use a multidose dry powder inhaler technology, also licensed from Pfizer.

December 17, 2013

Greenstone has launched a version of a drug used to treat fungal infections, the company said.

PEAPACK, N.J. — Greenstone has launched a version of a drug used to treat fungal infections, the company said.

Greenstone, the generics subsidiary of Pfizer, announced the introduction of voriconazole for oral suspension, an authorized generic version of Pfizer's Vfend. Authorized generics are branded drugs sold at a discount under their generic names.

Greenstone is selling the drug in the 40 mg-per-milliliter strength. Vfend had sales of about $17.1 million during the 12-month period that ended in June, according to IMS Health.

 

December 3, 2013

The Food and Drug Administration has given tentative approval to a generic drug for treating community-acquired pneumonia, agency records showed.

SILVER SPRING, Md. — The Food and Drug Administration has given tentative approval to a generic drug for treating community-acquired pneumonia, agency records showed.

According to the FDA's website, the agency granted the preliminary authorization for Roxane Labs' linezolid oral suspension in the 100-mg-per-5-mL strength.

December 2, 2013

Pfizer on Monday announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin (acidum acetylsalicylicum), and the leading over-the-counter brand for heart attack prevention in Poland, from ZF Polpharma SA.

NEW YORK — Pfizer on Monday announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin (acidum acetylsalicylicum), and the leading over-the-counter brand for heart attack prevention in Poland, from ZF Polpharma SA.

November 25, 2013

Pfizer on Monday launched Robitussin Maximum Strength Cough + Congestion DM, a new liquid-filled capsule that helps control cough on-the-go.

MADISON, N.J. — Pfizer on Monday launched Robitussin Maximum Strength Cough + Congestion DM, a new liquid-filled capsule that helps control cough on-the-go. "This formulation not only harnesses the power of Maximum Strength Robitussin cough liquid, but is a convenient option for those hitting the road or boarding a plane this holiday season," the company stated.

The company noted that whether traveling cross country or staying close to home, families can track when cough activity spikes in their local area via the Robitussin COUGHCAST tool. 

November 22, 2013

The Food and Drug Administration has granted regular approval to a new drug made by Pfizer for treating a form of lung cancer, the drug maker said.

NEW YORK — The Food and Drug Administration has granted regular approval to a new drug made by Pfizer for treating a form of lung cancer, the drug maker said.

November 6, 2013

A pharmacist in Canada has won a prestigious award from Pfizer Consumer Healthcare, according to published reports.

NEW YORK — A pharmacist in Canada has won a prestigious award from Pfizer Consumer Healthcare, according to published reports.

Nova Scotia's Truro Daily News reported that retired pharmacist Allan MacKinnon received the company's Bowl of Hygeia award during the weekend. Coworkers Kerry Mattatall and Marilyn MacLeod had put together the nomination package for MacKinnon, including 27 letters of support, citing the MacKinnons' support for their community.

November 5, 2013

The Food and Drug Administration has approved a generic drug made by Mylan for treating overactive bladder, according to agency records.

SILVER SPRING, Md. — The Food and Drug Administration has approved a generic drug made by Mylan for treating overactive bladder, according to agency records.

The FDA approved Mylan's tolterodine tartrate extended-release capsules in the 2-mg and 4-mg strengths.

The drug is a generic version of Pfizer's Detrol LA. Detrol LA has annual sales of about $700 million, according to published reports.

 

October 29, 2013

In what is emerging as the latest battle over follow-on biologics, a new argument has emerged about what to call them, and supporters of biotechnology companies are the latest to take a shot.

NEW YORK — In what is emerging as the latest battle over follow-on biologics, a new argument has emerged about what to call them, and supporters of biotechnology companies are the latest to take a shot.

October 9, 2013

Pfizer Consumer Healthcare, the makers of ChapStick, on Wednesday announced Alex Morgan, Olympic gold medalist and member of the U.S. Women’s National Soccer Team, as the brand’s newest spokeswoman.

MADISON, N.J. — Pfizer Consumer Healthcare, the makers of ChapStick, on Wednesday announced Alex Morgan, Olympic gold medalist and member of the U.S. Women’s National Soccer Team, as the brand’s newest spokeswoman. Morgan will serve as the first brand spokesperson in more than a decade and will appear in national television and print advertising, set to debut Nov. 4.

October 8, 2013

The Food and Drug Administration has approved a new treatment for hot flashes and the prevention of osteoporosis, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for hot flashes and the prevention of osteoporosis, the agency said.

The FDA announced the approval of Duavee (conjugated estrogens; bazedoxifene), made by Pfizer. The drug is for women who suffer from moderate to severe hot flashes associated with menopause, and is also designed to prevent osteoporosis after menopause.

September 30, 2013

Pfizer Consumer Healthcare and the National Hockey League on Monday announced Advil as the Official Partner and the Official Pain Reliever of the NHL and the 30 NHL athletic trainers in North America for the 2013-14 season.

NEW YORK — Pfizer Consumer Healthcare and the National Hockey League on Monday announced Advil as the Official Partner and the Official Pain Reliever of the NHL and the 30 NHL athletic trainers in North America for the 2013-14 season. Under the agreement, Advil is also an Official Partner and the Official Pain Reliever of the 2014 Bridgestone NHL Winter Classic and the 2014 Coors Light NHL Stadium Series. 

September 30, 2013

Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

PITTSBURGH — Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

The drug maker announced the launch of voriconazole for oral suspension in the 40-mg-per-mL strength. The drug is the first generic version of Pfizer's Vfend, and as the first company to receive approval for a generic version, Mylan has 180 days in which to compete exclusively against Pfizer's product. The drug is used to treat invasive fungal infections.

September 25, 2013

The board of directors of the World Self-Medication Industry on Wednesday named as its chair-elect Erica Mann, member of the Bayer HealthCare executive committee and president of Bayer HealthCare’s Global Consumer Care division.

LEVERKUSEN, Germany — The board of directors of the World Self-Medication Industry on Wednesday named as its chair-elect Erica Mann, member of the Bayer HealthCare executive committee and president of Bayer HealthCare’s Global Consumer Care division. Mann will succeed current chair Zhenyu Guo, CEO, Dihon Pharmaceutical at the completion of his term in June 2014.

September 13, 2013

ChapStick, part of the Pfizer portfolio of consumer brands, on Friday announced a new lip balm with advanced moisturizing and anti-aging ingredients.

Madison, N.J. — ChapStick, part of the Pfizer portfolio of consumer brands, on Friday announced a new lip balm with advanced moisturizing and anti-aging ingredients.

September 10, 2013

One trend that generic companies and pharmacy retailers alike should keep an eye on is the patent cliff.

One trend that generic companies and pharmacy retailers alike should keep an eye on is the patent cliff. One of the reasons why generic prescriptions will likely peak at 86% to 87%, Long said, is that after the patent on Crestor expires In 2016, there simply won't be a lot of top-selling branded drugs.

September 10, 2013

Pfizer Consumer recently launched its Advil Film Coated tablets, and the first-to-market formulation marks the debut of Advil Ion Core Technology in the United States.

MADISON, N.J. — Pfizer Consumer recently launched its Advil Film Coated tablets, and the first-to-market formulation marks the debut of Advil Ion Core Technology in the United States. This fast-dissolving technology along with a unique, specially formulated ultra-thin coating, is engineered for speed, going to work in minutes.

September 10, 2013

Generic drugs have been on a roll with their share of total prescriptions dispensed in the country seeming to increase on a nearly constant basis. But it appears the peak is coming soon.

Generic drugs have been on a roll with their share of total prescriptions dispensed in the country seeming to increase on a nearly constant basis. But it appears the peak is coming soon.

(For the full category review, including sales data, click here.)

September 4, 2013

A joint venture founded by GlaxoSmithKline and Pfizer focused on treatments for HIV has expanded its support of community organizations in the South.

RESEARCH TRIANGLE PARK, N.C. — A joint venture founded by GlaxoSmithKline and Pfizer focused on treatments for HIV has expanded its support of community organizations in the South.

August 26, 2013

Biotech company Amgen is buying Onyx Pharmaceuticals, the companies said Sunday.

THOUSAND OAKS, Calif. — Biotech company Amgen is buying Onyx Pharmaceuticals, the companies said Sunday.

Onyx, based in South San Francisco, Calif., has a portfolio of cancer drugs, including the injected multiple myeloma drug Kyprolis (carfilzomib), as well as Nexavar (sorafenib) tablets, developed with Bayer HealthCare Pharmaceuticals; Stivarga (regorafenib) tablets, developed by Bayer; and palbociclib, developed by Pfizer.

August 26, 2013

Pfizer Consumer Healthcare on Monday introduced Advil Film Coated tablets featuring a new, fast-dissolving technology, along with a specially formulated ultra-thin coating, that speeds the ibuprofen mode of action.

MADISON, N.J. — Pfizer Consumer Healthcare on Monday introduced Advil Film Coated tablets featuring a new, fast-dissolving technology, along with a specially formulated ultra-thin coating, that speeds the ibuprofen mode of action. According to the company, the new tablet provides the speed and power of a liquid filled capsule in the more popular tablet form.